106 related articles for article (PubMed ID: 24628262)
21. [Magnetic resonance in the study of cerebral gliomas].
Vaghi MA; Visciani A; Passerini A; Longone V; Broggi G
Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma.
Chang J; Thakur SB; Huang W; Narayana A
Technol Cancer Res Treat; 2008 Oct; 7(5):349-62. PubMed ID: 18783284
[TBL] [Abstract][Full Text] [Related]
23. Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study.
Himmelreich U; Dzendrowskyj TE; Allen C; Dowd S; Malik R; Shehan BP; Russell P; Mountford CE; Sorrell TC
Radiology; 2001 Jul; 220(1):122-8. PubMed ID: 11425983
[TBL] [Abstract][Full Text] [Related]
24. The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification.
Devos A; Simonetti AW; van der Graaf M; Lukas L; Suykens JA; Vanhamme L; Buydens LM; Heerschap A; Van Huffel S
J Magn Reson; 2005 Apr; 173(2):218-28. PubMed ID: 15780914
[TBL] [Abstract][Full Text] [Related]
25. Comments and controversies: magnetic resonance spectroscopy and gliomas.
Fan G
Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
27. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
[TBL] [Abstract][Full Text] [Related]
28. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
29. Differences in metabolism of fiber tract alterations in gliomas: a combined fiber density mapping and magnetic resonance spectroscopic imaging study.
Stadlbauer A; Hammen T; Buchfelder M; Bachmair J; Dörfler A; Nimsky C; Ganslandt O
Neurosurgery; 2012 Aug; 71(2):454-63. PubMed ID: 22517254
[TBL] [Abstract][Full Text] [Related]
30. Strengths and weaknesses of 1.5T and 3T MRS data in brain glioma classification.
Kounelakis MG; Dimou IN; Zervakis ME; Tsougos I; Tsolaki E; Kousi E; Kapsalaki E; Theodorou K
IEEE Trans Inf Technol Biomed; 2011 Jul; 15(4):647-54. PubMed ID: 21427025
[TBL] [Abstract][Full Text] [Related]
31. Proton MR spectroscopy of common brain tumors.
Castillo M; Kwock L
Neuroimaging Clin N Am; 1998 Nov; 8(4):733-52. PubMed ID: 9769340
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
33. Pulse sequence variations in NMR imaging for optimal discrimination of pathological tissue changes.
Bielke G; Brückner A; von Seelen W; Meindl S; Rinck P; Pfannenstiel P; Meves M
Prog Nucl Med; 1984; 8():65-70. PubMed ID: 6522614
[No Abstract] [Full Text] [Related]
34. Human brain tumors: assessment with in vivo proton MR spectroscopy.
Ott D; Hennig J; Ernst T
Radiology; 1993 Mar; 186(3):745-52. PubMed ID: 8430183
[TBL] [Abstract][Full Text] [Related]
35. Low-grade gliomas: the challenges of imaging.
Guillevin R; Herpe G; Verdier M; Guillevin C
Diagn Interv Imaging; 2014 Oct; 95(10):957-63. PubMed ID: 25195186
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
37. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
[TBL] [Abstract][Full Text] [Related]
38. [Advance of magnetic resonance spectroscopic imaging (MRSI) techniques].
Hirata S; Bito Y; Yamamoto E
Nihon Rinsho; 1994 Sep; 52(9):2473-82. PubMed ID: 7967099
[TBL] [Abstract][Full Text] [Related]
39. Brainstem gliomas.
Ramos A; Hilario A; Lagares A; Salvador E; Perez-Nuñez A; Sepulveda J
Semin Ultrasound CT MR; 2013 Apr; 34(2):104-12. PubMed ID: 23522775
[TBL] [Abstract][Full Text] [Related]
40. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
